Author:
Watanabe Kenji,Uchino Hiroshi,Ohmura Chie,Tanaka Yasushi,Onuma Tomio,Kawamori Ryuzo
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference19 articles.
1. Pharmacokinetics of acarbose: Part I. Absorption, concentration in plasma, metabolism and excretion after single administration of [14C] acarbose to rats, dogs and man;Ahr;Arzneimittel-Forschung,1989
2. Urinary excretion of 1,5-anhydro-d-glucitol accompanying glucose excretion in diabetic patients;Akanuma;Diabetologia,1988
3. Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus;Coniff;Archives of Internal Medicine,1994
4. The effects of the α-glucosidase inhibitor BAY g 5421 (acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man;Hillebrand;Research in Experimental Medicine (Berlin),1979
5. Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy;Hotta;Biomedicine & Pharmacotherapy,1996
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献